Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Brain+

Brain+

0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK
0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK

Brain+

Brain+

0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK
0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK

Brain+

Brain+

0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK
0,0024DKK
−25,00% (−0,0008)
Päätöskurssi
Ylin0,0048
Alin0,0010
Vaihto
0,4 MDKK
2025 H1 -tulosraportti
144 päivää sitten48 min

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
2 000 000
Myynti
Määrä
1 233 120

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
104 592--
716 658--
400 000--
883 342--
50 000--
Ylin
0,005
VWAP
0,003
Alin
0,001
VaihtoMäärä
0,4 160 601 331
VWAP
0,003
Ylin
0,005
Alin
0,001
VaihtoMäärä
0,4 160 601 331

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2025 H2 -tulosraportti
29.4.
Menneet tapahtumat
2025 H1 -tulosraportti4.9.2025
2024 H2 -tulosraportti29.4.2025
2024 H1 -tulosraportti3.9.2024
2023 H2 -tulosraportti7.5.2024
2023 H1 -tulosraportti1.9.2023

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 6 t sitten
    ·
    6 t sitten
    ·
    I am writing as a private individual and engaged investor in the digital health and dementia sector, with a sincere wish to contribute constructively to the development of a more coherent, scalable, and future-proof municipal dementia effort. There is today broad professional and political consensus that Cognitive Stimulation Therapy (CST) is an evidence-based, non-pharmacological intervention with documented effect for people with mild to moderate dementia. CST is also fully in line with national health strategies, dementia action plans, and the state's general focus on prevention, quality of life, functional capacity, and dignified elderly care. The central question is no longer whether CST works, but how it is delivered structured, uniformly, and scalably in municipal operations. Here, digital delivery is crucial. Digital CST platforms make it possible to: - ensure uniform quality in all municipalities - document effect, progression, and outcome - support staff through structure, planning, and documentation - reduce dependence on local resources and person-dependent solutions - create national standardization instead of fragmented local models At the same time, municipalities today face increasing dementia pressure, staff shortages, and growing demands for documentation, quality, and effect measurement. Therefore, I believe that time is now a critical factor. Not in 3–5 years, but now. I would therefore urge KL to consider a role as: - disseminator of knowledge about digital CST to the municipalities - national coordinating actor in relation to implementation - bridge-builder between state guidelines, municipal practice, and digital solutions - platform for common standards instead of individual municipal pilot projects Specifically, solutions already exist in the market, including the digital CST platform Ayla (from Brain+), which is used in both Denmark and UK, and which enables precisely structured, documented, and scalable delivery of CST in a municipal and care context. My wish with this inquiry is not to market a single actor, but to: 👉 draw attention to the importance of digital CST as a method 👉 point to the need for national dissemination instead of fragmented local rollout 👉 create awareness that the technology already exists 👉 emphasize that implementation speed is now crucial I would therefore like to ask if KL sees the possibility for: - mediating relevant contact to municipalities - creating dialogue about digital CST across municipalities - engaging in a more structured national dialogue about digital dementia initiatives I would be very happy to contribute further documentation, cases, or contact to relevant actors, if desired. https://www.brain-plus.com/ https://www.ayla-care.com/ Kind regards
    4 t sitten
    amwe@kl.dk alwe@kl.dk alpe@kl.dk altb@kl.dk pah@kl.dk pfl@kl.dk mobr@kl.dk lila@kl.dk knr@kl.dk jaei@kl.dk chch@kl.dk gdj@kl.dk kl@kl.dk gv0e@kk.dk mmd@kl.dk capl@kl.dk acj@kl.dk asth@kl.dk asfp@kl.dk akf@kl.dk ajep@kl.dk antj@kl.dk anhb@kl.dk ascm@kl.dk anho@kl.dk anhp@kl.dk anda@kl.dk anha@kl.dk acd@kl.dk acsm@kl.dk
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The restructuring of Brain+ should be seen as a strategic move. Today, the company is closer to a commercial breakthrough than ever before and can for the first time show a real, credible pipeline. This significantly changes the negotiation position. Precisely for this reason, the restructuring makes sense: It creates calm to make a sustainable agreement with the creditors and secure the future of the company. With a stronger starting point than before, Brain+ can now structure the debt, preserve the core of the business, and set sail for actual scaling. In the long term, this is the solution that provides the best opportunity to create value for the shareholders.
    7 t sitten
    ·
    7 t sitten
    ·
    That sounds right. Devika is aware that the price will fall now, but that it was better for the investors, and for the end-user in the short term, than the alternatives.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Does anyone know how much money they are trying to raise?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    I am by no means aware of what is going on at Brain+ right now, but from what I could immediately dig up, it was approximately 10 million kr. in net capital to be able to implement their UK commercialization plan. But that's just what I could find out on Google, so take it with a grain of salt.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    So the voting is finished. 23% will support with repayment of contributions + interest. 10% will support with shares as payment, and 10% with a combination of both. I will create a Gmail and post the address and instructions, then I will collect everything and hand it over to Devika and Otto.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Is it shown how many people have voted in total?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    30 people. But commitment to interest, shares or combination, has been stable around 23%, 8-10%. The only thing that changed was an increase of those who cannot and a decrease for those who will not.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Resharing my observations from March 25: The webinar raised more doubts than clarifications. Overall red flags: • No tracking of what works • No organic content marketing • Very little systematic setup Devika joined 8 months ago. High time. She and Fionia are the only lottery tickets imo in +Brain. Because how can one seriously have run a publicly listed company without going through one's startup's ABCs, including keyword analysis and SEO optimization. They had and still don't have a long-term plan to acquire customers digitally. And their product is, after all, digital... Just a reminder that ad prices are rising on most platforms and that the necessity to drive traffic oneself is therefore imo damn essential. Especially for a small company that burns so much cash. And precisely expensive personnel is reprehensible. It is in no way run like the startup it is. The emission is therefore really imo a pretext for a rescue plan. I do believe the focus shift to UK with a lower sales process is well-judged. But almost sales is not sales until it is sales. Period. They were also 70% there 3 weeks ago and still nothing new... not even a couple of small orders in UK would cheer me up anymore. Devika answers btw that only 12,5% of those they have raised in advance come from management. That is very little imo. Because it's not like they haven't earned in their paycheck: 12.099.741 (2022) 16 employees 11.039.670 (2023) 13 employees That is therefore above the top tax bracket limit if everyone, mind you, received the median salary, which is hardly the case. Many other entrepreneurs would have shown more care with their liquidity.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    You are wrong Anewfire. You also don't understand the product and how it should be sold. It's not an online game where we want everyone to buy the product. It is an approved medical product, which must be sold to private and public healthcare actors. You can read through the threads and the news and see what has been reported about sales.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 H1 -tulosraportti
144 päivää sitten48 min

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 6 t sitten
    ·
    6 t sitten
    ·
    I am writing as a private individual and engaged investor in the digital health and dementia sector, with a sincere wish to contribute constructively to the development of a more coherent, scalable, and future-proof municipal dementia effort. There is today broad professional and political consensus that Cognitive Stimulation Therapy (CST) is an evidence-based, non-pharmacological intervention with documented effect for people with mild to moderate dementia. CST is also fully in line with national health strategies, dementia action plans, and the state's general focus on prevention, quality of life, functional capacity, and dignified elderly care. The central question is no longer whether CST works, but how it is delivered structured, uniformly, and scalably in municipal operations. Here, digital delivery is crucial. Digital CST platforms make it possible to: - ensure uniform quality in all municipalities - document effect, progression, and outcome - support staff through structure, planning, and documentation - reduce dependence on local resources and person-dependent solutions - create national standardization instead of fragmented local models At the same time, municipalities today face increasing dementia pressure, staff shortages, and growing demands for documentation, quality, and effect measurement. Therefore, I believe that time is now a critical factor. Not in 3–5 years, but now. I would therefore urge KL to consider a role as: - disseminator of knowledge about digital CST to the municipalities - national coordinating actor in relation to implementation - bridge-builder between state guidelines, municipal practice, and digital solutions - platform for common standards instead of individual municipal pilot projects Specifically, solutions already exist in the market, including the digital CST platform Ayla (from Brain+), which is used in both Denmark and UK, and which enables precisely structured, documented, and scalable delivery of CST in a municipal and care context. My wish with this inquiry is not to market a single actor, but to: 👉 draw attention to the importance of digital CST as a method 👉 point to the need for national dissemination instead of fragmented local rollout 👉 create awareness that the technology already exists 👉 emphasize that implementation speed is now crucial I would therefore like to ask if KL sees the possibility for: - mediating relevant contact to municipalities - creating dialogue about digital CST across municipalities - engaging in a more structured national dialogue about digital dementia initiatives I would be very happy to contribute further documentation, cases, or contact to relevant actors, if desired. https://www.brain-plus.com/ https://www.ayla-care.com/ Kind regards
    4 t sitten
    amwe@kl.dk alwe@kl.dk alpe@kl.dk altb@kl.dk pah@kl.dk pfl@kl.dk mobr@kl.dk lila@kl.dk knr@kl.dk jaei@kl.dk chch@kl.dk gdj@kl.dk kl@kl.dk gv0e@kk.dk mmd@kl.dk capl@kl.dk acj@kl.dk asth@kl.dk asfp@kl.dk akf@kl.dk ajep@kl.dk antj@kl.dk anhb@kl.dk ascm@kl.dk anho@kl.dk anhp@kl.dk anda@kl.dk anha@kl.dk acd@kl.dk acsm@kl.dk
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The restructuring of Brain+ should be seen as a strategic move. Today, the company is closer to a commercial breakthrough than ever before and can for the first time show a real, credible pipeline. This significantly changes the negotiation position. Precisely for this reason, the restructuring makes sense: It creates calm to make a sustainable agreement with the creditors and secure the future of the company. With a stronger starting point than before, Brain+ can now structure the debt, preserve the core of the business, and set sail for actual scaling. In the long term, this is the solution that provides the best opportunity to create value for the shareholders.
    7 t sitten
    ·
    7 t sitten
    ·
    That sounds right. Devika is aware that the price will fall now, but that it was better for the investors, and for the end-user in the short term, than the alternatives.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Does anyone know how much money they are trying to raise?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    I am by no means aware of what is going on at Brain+ right now, but from what I could immediately dig up, it was approximately 10 million kr. in net capital to be able to implement their UK commercialization plan. But that's just what I could find out on Google, so take it with a grain of salt.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    So the voting is finished. 23% will support with repayment of contributions + interest. 10% will support with shares as payment, and 10% with a combination of both. I will create a Gmail and post the address and instructions, then I will collect everything and hand it over to Devika and Otto.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Is it shown how many people have voted in total?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    30 people. But commitment to interest, shares or combination, has been stable around 23%, 8-10%. The only thing that changed was an increase of those who cannot and a decrease for those who will not.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Resharing my observations from March 25: The webinar raised more doubts than clarifications. Overall red flags: • No tracking of what works • No organic content marketing • Very little systematic setup Devika joined 8 months ago. High time. She and Fionia are the only lottery tickets imo in +Brain. Because how can one seriously have run a publicly listed company without going through one's startup's ABCs, including keyword analysis and SEO optimization. They had and still don't have a long-term plan to acquire customers digitally. And their product is, after all, digital... Just a reminder that ad prices are rising on most platforms and that the necessity to drive traffic oneself is therefore imo damn essential. Especially for a small company that burns so much cash. And precisely expensive personnel is reprehensible. It is in no way run like the startup it is. The emission is therefore really imo a pretext for a rescue plan. I do believe the focus shift to UK with a lower sales process is well-judged. But almost sales is not sales until it is sales. Period. They were also 70% there 3 weeks ago and still nothing new... not even a couple of small orders in UK would cheer me up anymore. Devika answers btw that only 12,5% of those they have raised in advance come from management. That is very little imo. Because it's not like they haven't earned in their paycheck: 12.099.741 (2022) 16 employees 11.039.670 (2023) 13 employees That is therefore above the top tax bracket limit if everyone, mind you, received the median salary, which is hardly the case. Many other entrepreneurs would have shown more care with their liquidity.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    You are wrong Anewfire. You also don't understand the product and how it should be sold. It's not an online game where we want everyone to buy the product. It is an approved medical product, which must be sold to private and public healthcare actors. You can read through the threads and the news and see what has been reported about sales.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
2 000 000
Myynti
Määrä
1 233 120

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
104 592--
716 658--
400 000--
883 342--
50 000--
Ylin
0,005
VWAP
0,003
Alin
0,001
VaihtoMäärä
0,4 160 601 331
VWAP
0,003
Ylin
0,005
Alin
0,001
VaihtoMäärä
0,4 160 601 331

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2025 H2 -tulosraportti
29.4.
Menneet tapahtumat
2025 H1 -tulosraportti4.9.2025
2024 H2 -tulosraportti29.4.2025
2024 H1 -tulosraportti3.9.2024
2023 H2 -tulosraportti7.5.2024
2023 H1 -tulosraportti1.9.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 H1 -tulosraportti
144 päivää sitten48 min

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2025 H2 -tulosraportti
29.4.
Menneet tapahtumat
2025 H1 -tulosraportti4.9.2025
2024 H2 -tulosraportti29.4.2025
2024 H1 -tulosraportti3.9.2024
2023 H2 -tulosraportti7.5.2024
2023 H1 -tulosraportti1.9.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 6 t sitten
    ·
    6 t sitten
    ·
    I am writing as a private individual and engaged investor in the digital health and dementia sector, with a sincere wish to contribute constructively to the development of a more coherent, scalable, and future-proof municipal dementia effort. There is today broad professional and political consensus that Cognitive Stimulation Therapy (CST) is an evidence-based, non-pharmacological intervention with documented effect for people with mild to moderate dementia. CST is also fully in line with national health strategies, dementia action plans, and the state's general focus on prevention, quality of life, functional capacity, and dignified elderly care. The central question is no longer whether CST works, but how it is delivered structured, uniformly, and scalably in municipal operations. Here, digital delivery is crucial. Digital CST platforms make it possible to: - ensure uniform quality in all municipalities - document effect, progression, and outcome - support staff through structure, planning, and documentation - reduce dependence on local resources and person-dependent solutions - create national standardization instead of fragmented local models At the same time, municipalities today face increasing dementia pressure, staff shortages, and growing demands for documentation, quality, and effect measurement. Therefore, I believe that time is now a critical factor. Not in 3–5 years, but now. I would therefore urge KL to consider a role as: - disseminator of knowledge about digital CST to the municipalities - national coordinating actor in relation to implementation - bridge-builder between state guidelines, municipal practice, and digital solutions - platform for common standards instead of individual municipal pilot projects Specifically, solutions already exist in the market, including the digital CST platform Ayla (from Brain+), which is used in both Denmark and UK, and which enables precisely structured, documented, and scalable delivery of CST in a municipal and care context. My wish with this inquiry is not to market a single actor, but to: 👉 draw attention to the importance of digital CST as a method 👉 point to the need for national dissemination instead of fragmented local rollout 👉 create awareness that the technology already exists 👉 emphasize that implementation speed is now crucial I would therefore like to ask if KL sees the possibility for: - mediating relevant contact to municipalities - creating dialogue about digital CST across municipalities - engaging in a more structured national dialogue about digital dementia initiatives I would be very happy to contribute further documentation, cases, or contact to relevant actors, if desired. https://www.brain-plus.com/ https://www.ayla-care.com/ Kind regards
    4 t sitten
    amwe@kl.dk alwe@kl.dk alpe@kl.dk altb@kl.dk pah@kl.dk pfl@kl.dk mobr@kl.dk lila@kl.dk knr@kl.dk jaei@kl.dk chch@kl.dk gdj@kl.dk kl@kl.dk gv0e@kk.dk mmd@kl.dk capl@kl.dk acj@kl.dk asth@kl.dk asfp@kl.dk akf@kl.dk ajep@kl.dk antj@kl.dk anhb@kl.dk ascm@kl.dk anho@kl.dk anhp@kl.dk anda@kl.dk anha@kl.dk acd@kl.dk acsm@kl.dk
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The restructuring of Brain+ should be seen as a strategic move. Today, the company is closer to a commercial breakthrough than ever before and can for the first time show a real, credible pipeline. This significantly changes the negotiation position. Precisely for this reason, the restructuring makes sense: It creates calm to make a sustainable agreement with the creditors and secure the future of the company. With a stronger starting point than before, Brain+ can now structure the debt, preserve the core of the business, and set sail for actual scaling. In the long term, this is the solution that provides the best opportunity to create value for the shareholders.
    7 t sitten
    ·
    7 t sitten
    ·
    That sounds right. Devika is aware that the price will fall now, but that it was better for the investors, and for the end-user in the short term, than the alternatives.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Does anyone know how much money they are trying to raise?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    I am by no means aware of what is going on at Brain+ right now, but from what I could immediately dig up, it was approximately 10 million kr. in net capital to be able to implement their UK commercialization plan. But that's just what I could find out on Google, so take it with a grain of salt.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    So the voting is finished. 23% will support with repayment of contributions + interest. 10% will support with shares as payment, and 10% with a combination of both. I will create a Gmail and post the address and instructions, then I will collect everything and hand it over to Devika and Otto.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Is it shown how many people have voted in total?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    30 people. But commitment to interest, shares or combination, has been stable around 23%, 8-10%. The only thing that changed was an increase of those who cannot and a decrease for those who will not.
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    Resharing my observations from March 25: The webinar raised more doubts than clarifications. Overall red flags: • No tracking of what works • No organic content marketing • Very little systematic setup Devika joined 8 months ago. High time. She and Fionia are the only lottery tickets imo in +Brain. Because how can one seriously have run a publicly listed company without going through one's startup's ABCs, including keyword analysis and SEO optimization. They had and still don't have a long-term plan to acquire customers digitally. And their product is, after all, digital... Just a reminder that ad prices are rising on most platforms and that the necessity to drive traffic oneself is therefore imo damn essential. Especially for a small company that burns so much cash. And precisely expensive personnel is reprehensible. It is in no way run like the startup it is. The emission is therefore really imo a pretext for a rescue plan. I do believe the focus shift to UK with a lower sales process is well-judged. But almost sales is not sales until it is sales. Period. They were also 70% there 3 weeks ago and still nothing new... not even a couple of small orders in UK would cheer me up anymore. Devika answers btw that only 12,5% of those they have raised in advance come from management. That is very little imo. Because it's not like they haven't earned in their paycheck: 12.099.741 (2022) 16 employees 11.039.670 (2023) 13 employees That is therefore above the top tax bracket limit if everyone, mind you, received the median salary, which is hardly the case. Many other entrepreneurs would have shown more care with their liquidity.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    You are wrong Anewfire. You also don't understand the product and how it should be sold. It's not an online game where we want everyone to buy the product. It is an approved medical product, which must be sold to private and public healthcare actors. You can read through the threads and the news and see what has been reported about sales.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
2 000 000
Myynti
Määrä
1 233 120

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
104 592--
716 658--
400 000--
883 342--
50 000--
Ylin
0,005
VWAP
0,003
Alin
0,001
VaihtoMäärä
0,4 160 601 331
VWAP
0,003
Ylin
0,005
Alin
0,001
VaihtoMäärä
0,4 160 601 331

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt